21 related articles for article (PubMed ID: 20055855)
1. Correlation of Occupational Exposure to Carcinogenic Polycyclic Aromatic Hydrocarbons (cPAHs) and Blood Levels of p53 and p21 Proteins.
Saleh SAK; Adly HM; Aljahdali IA; Khafagy AA
Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204761
[TBL] [Abstract][Full Text] [Related]
2. Genotoxic hazard and cellular stress in pediatric patients treated for psoriasis with the Goeckerman regimen.
Borska L; Andrys C; Krejsek J; Hamakova K; Kremlacek J; Ettler K; Vellappally S; Vimal J; Fiala Z
Pediatr Dermatol; 2009; 26(1):23-7. PubMed ID: 19250400
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of the pro-inflammatory cytokine interleukin-12 and the anti-inflammatory cytokine interleukin-10 in patients with psoriasis treated by the Goeckerman regimen.
Borska L; Andrys C; Krejsek J; Hamakova K; Kremlacek J; Ettler K; Fiala Z
Int J Dermatol; 2008 Aug; 47(8):800-5. PubMed ID: 18717859
[TBL] [Abstract][Full Text] [Related]
4. Genotoxic and apoptotic effects of Goeckerman therapy for psoriasis.
Borska L; Andrys C; Krejsek J; Hamakova K; Kremlacek J; Palicka V; Ranna D; Fiala Z
Int J Dermatol; 2010 Mar; 49(3):289-94. PubMed ID: 20465666
[TBL] [Abstract][Full Text] [Related]
5. Possible genotoxic risk of combined exposure to pharmaceutical coal tar and UV-B radiation.
Borská L; Fiala Z; Smejkalová J; Hamáková K; Kremlácek J
Cent Eur J Public Health; 2004 Mar; 12 Suppl():S14-5. PubMed ID: 15141964
[TBL] [Abstract][Full Text] [Related]
6. Genotoxic effect of Goeckerman regimen of psoriasis.
Fiala Z; Borska L; Pastorkova A; Kremlacek J; Cerna M; Smejkalova J; Hamakova K
Arch Dermatol Res; 2006 Oct; 298(5):243-51. PubMed ID: 16902768
[TBL] [Abstract][Full Text] [Related]
7. The Patient's Guide to Psoriasis Treatment. Part 4: Goeckerman Therapy.
Zhu TH; Nakamura M; Farahnik B; Abrouk M; Singh RK; Lee KM; Hulse S; Koo J; Bhutani T; Liao W
Dermatol Ther (Heidelb); 2016 Sep; 6(3):333-9. PubMed ID: 27474032
[TBL] [Abstract][Full Text] [Related]
8. Pathologic findings in internal organs in psoriasis.
Zachariae H
Int J Dermatol; 1994 May; 33(5):323-6. PubMed ID: 8039970
[No Abstract] [Full Text] [Related]
9. Plasma levels of p53 protein and chromosomal aberrations in patients with psoriasis treated with the Goeckerman regimen.
Borska L; Andrys C; Krejsek J; Hamakova K; Kremlacek J; Ranna D; Kotingova L; Fiala Z
Clin Exp Dermatol; 2009 Dec; 34(8):e881-3. PubMed ID: 20055855
[TBL] [Abstract][Full Text] [Related]
10. Goeckerman therapy for the treatment of eczema: a practical guide and review of efficacy.
Dennis M; Bhutani T; Koo J; Liao W
J Dermatolog Treat; 2013 Feb; 24(1):2-6. PubMed ID: 21797807
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
